Market Projections & Pipeline

The global artificial intelligence in drug discovery market was valued at USD 1.1 billion in 2022.

It is projected to expand at a compound annual growth rate (CAGR) of 29.6% from 2023 to 2030

HIV Pipeline

Peptide Capsid Inhibitor:

Non-peptide Capsid Inhibitor:

HIV-Monoclonal Antibody(Clone-3)

HIV-Monoclonal Antibody(Clone-7)

STC-CI-01(Pep-1), Univ of Missouri

STC-CI-07

Entry Inhibitors:

Viral Replication Inhibitors:

SARS-CoV-2 Monoclonal Antibody

STC-EI-N01, Univ of Missouri

STC-EI-K01 STC-EI-C01

STC-NI-K01 STC-NI-C01

For more information on our services and research projects, please click here to submit an enquiry.